亚洲是世界上乙型病毒性肝炎(hepatitis B,HB)的主要患病区,而我国是亚洲最主要的患病国[1]。由HB发展为肝硬化和肝癌需要经过较长的时间,故在未来20年内与HB相关的肝硬化和肝癌的患病率、发病率仍会持续在较高水平,这成为威胁我国人民健康和生命的重要公共卫生问题[2]。由于慢性HB、肝硬化和肝癌病程长,表现隐匿且具有传染性,疾病负担重,多数患者的主要病程进展在社区而非医院,但对该类病例准 Asia is the main diseased area of ​​hepatitis B (HB) in the world, and our country is the most important diseased country in Asia [1]. It takes a long time to develop cirrhosis and liver cancer from HB, so the prevalence and incidence of cirrhosis and liver cancer related to HB in the next 20 years will still be at a high level, which has become a threat to our people’s health and Important public health issues of life [2]. Because chronic HB, cirrhosis and hepatocellular carcinoma have a long course, are obscure and contagious, and have a heavy burden of disease, the majority of patients progress primarily in the community rather than in the hospital, but for such cases,